WASHINGTON – With robust public participation over the course of 17 prior events, the National Prescription Drug Take Back Day Initiative continues to remove ever-higher amounts of opioids and other medicines from the nation’s homes, where they are vulnerable to misuse, theft or abuse by family members and visitors, including...

FRESNO, Calif. — A federal grand jury returned a five-count indictment today against Israel Chavez Tamayo, 33, of Fresno, charging him with conspiracy to distribute and possess with the intent to distribute methamphetamine, cocaine, and heroin, distribution of cocaine, distribution of methamphetamine, and two counts of possessing methamphetamine and heroin...

WASHINGTON – First Lady Melania Trump today joined DEA Acting Administrator Uttam Dhillon to celebrate the official launch of the 2019 Red Ribbon campaign, dedicated to preserving the memory of DEA Special Agent Enrique “Kiki” Camarena – a DEA special agent who was kidnapped, tortured, and murdered in Mexico by...

WASHINGTON – The U.S. Drug Enforcement Administration and the U.S. Food and Drug Administration have issued warning letters to four website owners of rogue online pharmacies offering to distribute or dispense controlled substances, including opioids, and advertising their sale in violation of federal law. This is the first time the...

SACRAMENTO, Calif. — After a three-day trial, James Randolph Sherman, 55, of Stockton, was found guilty today of eight counts related to his heroin and crack cocaine trafficking operation, U.S. Attorney McGregor W. Scott and DEA San Francisco Division Special Agent in Charge Chris Nielsen announced. According to evidence presented...

WASHINGTON – In an effort to reduce the availability of deadly illegal fentanyl in America, the U.S. Drug Enforcement Administration has proposed to control three substances used by operators of clandestine laboratories to illicitly manufacture the deadly Schedule II controlled substance. Two Notices of Proposed Rulemaking were published in the...

WASHINGTON – The U.S. Drug Enforcement Administration is proposing to reduce the amount of five Schedule II opioid controlled substances that can be manufactured in the United States next year compared with 2019, per the Notice of Proposed Rulemaking being published in the Federal Register tomorrow and available for public...

SACRAMENTO, Calif. – A federal grand jury returned a four-count indictment today against Matthew Lee Roberson, 36, and Randy Lee Collins, 61, both of Rancho Cordova, Calif. The indictment charges Roberson with heroin and methamphetamine dealing as well as being a felon in possession of a firearm. The indictment charges...

FRESNO, Calif. — Halen Steven Patrick Frazier, 33, of Lone Jack, Missouri, entered a guilty plea to conspiring to distribute and possess with intent to distribute marijuana, which was shipped from California to Kansas City, Drug Enforcement Administration San Francisco Division Special Agent in Charge Chris Nielsen and U.S. Attorney...

WASHINGTON – The Drug Enforcement Administration today announced that it is moving forward to facilitate and expand scientific and medical research for marijuana in the United States. The DEA is providing notice of pending applications from entities applying to be registered to manufacture marijuana for researchers. DEA anticipates that registering...